Diabetes Research and Clinical Practice
Volume 87, Issue 1 , Pages 51-56 , January 2010

Serum N-terminal-pro-brain natriuretic peptide (NT-pro-BNP) and homocysteine levels in type 2 diabetic patients with asymptomatic left ventricular diastolic dysfunction

  • U. Görmüş

      Affiliations

    • Department of Molecular Medicine, Institute of Experimental Medical Research, İstanbul University, İstanbul, Turkey
    • ,
  • D. Özmen

      Affiliations

    • Department of Clinical Biochemistry, Ege University School of Medicine, İzmir 35100, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90 232 3903378; fax: +90 232 3392144.
    • ,
  • B. Özmen

      Affiliations

    • Department of Endocrinology, Celal Bayar University School of Medicine, Manisa 45100, Turkey
    • ,
  • Z. Parıldar

      Affiliations

    • Department of Clinical Biochemistry, Ege University School of Medicine, İzmir 35100, Turkey
    • ,
  • Ö. Özdoğan

      Affiliations

    • Department of Cardiology, Ege University School of Medicine, İzmir 35100, Turkey
    • ,
  • I. Mutaf

      Affiliations

    • Department of Clinical Biochemistry, Ege University School of Medicine, İzmir 35100, Turkey
    • ,
  • O. Bayındır

      Affiliations

    • Department of Clinical Biochemistry, Ege University School of Medicine, İzmir 35100, Turkey

Received 25 May 2009 ,Revised 6 October 2009 ,Accepted 19 October 2009.

References 

  1. Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care. 2001;24:5–10
  2. Raev DC. Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type I diabetic patients. Diabetes Care. 1994;17:633–639
  3. Shimabukuro M, Higa N, Oshiro Y, Asahi T, Takasu N. Diagnostic Utility of brain-natriuretic peptide for left ventricular diastolic dysfunction in asymptomatic type 2 diabetic patients. Diabetes Obes. Metabol. 2007;9:323–329
  4. Herrmann M, Taban-Shomal O, Hübner U, Böhm M, Herrmann W. A review of homocysteine and heart failure. Eur. J. Heart Fail. 2006;8(6):571–576
  5. Vasan RS, Beiser A, D’Agostino RB, Levy D, Selhub J, Jacques PF, et al. Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. J. Am. Med Assoc. 2003;289:1251–1257
  6. Herrmann W, Herrmann M, Joseph J, Tyagi SC. Homocysteine, brain natriuretic peptide and chronic heart failure: a critical review. Clin. Chem. Lab. Med. 2007;45:1633–1644
  7. Epshteyn V, Morrison K, Krishnaswamy P, Kazanegra R, Clopton P, Mudaliar S, et al. Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes. Diabetes Care. 2003;26:2081–2087
  8. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, et al. Biochemical detection of left ventricular systolic dysfunction. Lancet. 1998;351:9–13
  9. Krishnaswamy P, Lubien E, Clopton P, Koon J, Kazanegra R, Wanner E, et al. Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am. J. Med. 2001;111:274–279
  10. Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction comparison with Doppler velocity recordings. Circulation. 2002;105:595–601
  11. Magnusson M, Melander O, Israelsson B, Grubb A, Groop L, Jovinge S. Elevated plasma levels of NT-proBNP in patients without overt cardiovascular disease. Diabetes Care. 2004;27:1929–1935
  12. Andersen NH, Poulsen SH, Knudsen ST, Heickendorff L, Mogensen CE. NT-proBNP in normoalbuminuric patients with type 2 diabetes mellitus. Diab. Med. 2005;22:188–195
  13. Herrmann M, Muller S, Kindermann I, Gunther L, Konig J, Bohm M, et al. Plasma B vitamins and their relation to the severity of chronic heart failure. Am. J. Clin. Nutr. 2007;85:117–123
  14. Herrmann M, Kindermann I, Muller S, Georg T, Kindermann M, Bohm M, et al. Relationship of plasma homocysteine with the severity of chronic heart failure. Clin. Chem. 2005;51:1512–1515
  15. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(Suppl. 1):S5–S20
  16. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenhaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography American Society of Echocardiography Committee on Standards. Subcommittee on quantitation of two-dimensional echocardiograms. J. Am. Soc. Echocardiogr. 1989;2:358–367
  17. Levey As , Grene T, Kusek JW, Beck Gj. A simplified equation to predict glomerular filtration rate from serum creatinine (Abstract). J. Am. Soc. Nephrol. 2000;11:A0828
  18. Piccini J, Klein L, Gheorghiade M, Bonow RO. New insights into diastolic heart failure: role of diabetes mellitus. Am. J. Med. 2004;116(5A):64S–75S
  19. Cosson S. Usefulness of B-type natriuretic peptide (BNP) as a screen for left ventricular abnormalities in diabetes mellitus. Diabetes Metab. 2004;30:381–386
  20. Valle R, Bagolin E, Canali C, Glovinazzo P, Barro S, Aspromonta N, et al. The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients. Eur. J. Echocardiogr. 2006;7:40–44
  21. Albertini JP, Cohen R, Valensi P, Sachs RN, Charniot JC. B-type natriuretic peptide, a marker of aymptomatic left ventricular dysfunction in type 2 diabetic patients. Diabetes Metab. 2008;34:355–362
  22. Fang ZY, Schull-Meade R, Leano R, Mottram PM, Prins JB, Marwick TH. Screening for heart disease in diabetic subjects. Am. Heart J. 2005;149:349–354
  23. Butler R, Mcdonald TM, Struthers AD, Morris AD. The clinical implications of diabetic heart disease. Eur. Heart J. 1998;19:1617–1627
  24. Verges B, Zeller M, Desgres J, Dentan G, Laurent Y, Janin-Manificat L, et al. High plasma N-terminal probrain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock. Eur. Heart J. 2005;26:1734–1741
  25. Sundström J, Sullivan L, Selhub J, Benjamin EJ, D’Agostino RB, Jacques PF, et al. Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart Study. Eur. Heart J. 2004;25:523–530
  26. Joseph J, Washington A, Joseph L, Koehler L, Fink LM, Hauer-Jensen M, et al. Hyperhomocysteinemia leads to adverse cardiac remodeling in hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 2002;283:H2567–H2574
  27. Devi S, Kennedy RH, Joseph L, Shekhawat NS, Melchert RB, Joseph J. Effect of long-term hyperhomocysteinemia on myocardial structure and function in hypertensive rats. Cardiovasc. Pathol. 2006;15:75–82
  28. Joseph J, Joseph L, Shekhawat NS, Devi S, Wang J, Melchert RB, et al. Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats. Am. J. Physiol. Heart Circ. Physiol. 2003;285:H679–H686
  29. Herrmann M, Taban-Shoma O, Hubner U, Pexa A, Kilter H, Umanskaya N, et al. Hyperhomocysteinemia and myocardial expression of brain natriuretic peptide in rats. Clin. Chem. 2007;53:773–780
  30. Herrmann M, Wildemann B, Claes L, Klohs S, Ohnmacht M, Taban-Shomal O, et al. Experimental hyperhomocysteinemia reduces bone quality in rats. Clin. Chem. 2007;53:1455–1461
  31. Emoto M, Kanda H, Shoji T, Kawagishi T, Komatsu M, Mori K, et al. Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. Diabetes Care. 2001;24:533–538
  32. West IC. Radical and oxidative stress in diabetes. Diabet. Med. 2000;17:171–180
  33. Tyagi SC, Rodriguez W, Patel AM, Roberts AM, Falcone JF, Passmore JC, et al. Hyperhomocysteinemic diabetic cardiomyopathy: Oxidative stress, remodeling, and endothelial-myocyte uncoupling. J. Cardiovasc. Pharmacol. Therapeut. 2005;10:1–10

PII: S0168-8227(09)00435-5

doi: 10.1016/j.diabres.2009.10.010

Diabetes Research and Clinical Practice
Volume 87, Issue 1 , Pages 51-56 , January 2010

Article Tools

* Image Usage & Resolution